Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business
  2. News
  3. vasculitis
Show results for
Products
Services
Companies
News
Articles
Videos
Refine by
Date

Vasculitis Articles & Analysis

3 news found
Bayer submits aflibercept 8 mg for marketing authorization in Japan

Bayer submits aflibercept 8 mg for marketing authorization in Japan

In both trials, there were no cases of endophthalmitis, retinal vasculitis and no new safety signals through to week 48. Aflibercept 8 mg is being jointly developed by Bayer and Regeneron. ...

ByBayer AG

Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU

Bayer submits aflibercept 8 mg for regulatory approval in two major retinal eye diseases in the EU

In both trials, there were no cases of endophthalmitis, retinal vasculitis and no new safety signals through week 48. Aflibercept 8 mg is being jointly developed by Bayer and Regeneron. ...

ByBayer AG

Detailed data from pivotal studies with aflibercept 8 mg demonstrate sustained improvements in visual acuity and anatomic measures with large majority of patients maintaining treatment intervals of 16 weeks at week 48

Detailed data from pivotal studies with aflibercept 8 mg demonstrate sustained improvements in visual acuity and anatomic measures with large majority of patients maintaining treatment intervals of 16 weeks at week 48

Furthermore, there were no cases of occlusive retinal vasculitis or endophthalmitis in either trial, and non-ocular events were balanced between all treatment groups with no new signals. ...

ByBayer AG

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you